Novel Oral Anti-Obesity Agents: New Perspectives with Lorcaserin?

Lorcaserin: A Review of its Use in Chronic Weight Management

(2013) Sheridan M. Hoy   DRUGS

Phentermine and Topiramate Extended Release (Qsymia™)

(2012) Fiona Cameron et al.   DRUGS

Anti-obesity drugs: a review about their effects and their safety

(2012) Giuseppe Derosa et al.   Expert Opinion On Drug Safety

Effects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes

(2012) David Bradley et al.   GASTROENTEROLOGY

Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study

(2012) Patrick M. O'Neil et al.   Obesity

Weight Loss Surgery for Mild to Moderate Obesity: A Systematic Review and Economic Evaluation

(2012) Joanna Picot et al.   OBESITY SURGERY

The number of years lived with obesity and the risk of all-cause and cause-specific mortality

(2011) A. Abdullah et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

(2011) A Astrup et al.   INTERNATIONAL JOURNAL OF OBESITY

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

(2011) Meredith C. Fidler et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Pharmacological Treatment and Management of Obesity

(2011) Syed Sufyan Hussain et al.   POSTGRADUATE MEDICINE

Cardiovascular Risk-Benefit Profile of Sibutramine

(2010) A.J. Scheen   American Journal of Cardiovascular Drugs

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Medical Risks of Obesity

(2009) Xavier Pi-Sunyer   POSTGRADUATE MEDICINE